City-wide wastewater genomic surveillance through the successive emergence of SARS-CoV-2 Alpha and Delta variants.
City-wide wastewater genomic surveillance through the successive emergence of SARS-CoV-2 Alpha and Delta variants.
复制标题
DOI:
10.1016/j.watres.2022.119306
复制
发表时间:
2022-11-01
期刊:
影响因子:
12.8
通讯作者:
Paterson, S.
中科院分区:
文献类型:
--
作者:
Brunner, F. S.;Brown, M. R.;Bassano, I;Denise, H.;Khalifa, M. S.;Wade, M. J.;van Aerle, R.;Kevill, J. L.;Jones, D. L.;Farkas, K.;Jeffries, A. R.;Cairns, E.;Wierzbicki, C.;Paterson, S.
关键词:
Genomic surveillance of SARS-CoV-2 has provided a critical evidence base for public health decisions throughout the pandemic. Sequencing data from clinical cases has helped to understand disease transmission and the spread of novel variants. Genomic wastewater surveillance can offer important, complementary information by providing frequency estimates of all variants circulating in a population without sampling biases. Here we show that genomic SARS-CoV-2 wastewater surveillance can detect fine-scale differences within urban centres, specifically within the city of Liverpool, UK, during the emergence of Alpha and Delta variants between November 2020 and June 2021. Furthermore, wastewater and clinical sequencing match well in the estimated timing of new variant rises and the first detection of a new variant in a given area may occur in either clinical or wastewater samples. The study's main limitation was sample quality when infection prevalence was low in spring 2021, resulting in a lower resolution of the rise of the Delta variant compared to the rise of the Alpha variant in the previous winter. The correspondence between wastewater and clinical variant frequencies demonstrates the reliability of wastewater surveillance. However, discrepancies in the first detection of the Alpha variant between the two approaches highlight that wastewater monitoring can also capture missing information, possibly resulting from asymptomatic cases or communities less engaged with testing programmes, as found by a simultaneous surge testing effort across the city.
登录
查看更多内容
DOI:
10.1126/science.abg3055
发表时间:
2021-04-09
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Davies NG;Abbott S;Barnard RC;Jarvis CI;Kucharski AJ;Munday JD;Pearson CAB;Russell TW;Tully DC;Washburne AD;Wenseleers T;Gimma A;Waites W;Wong KLM;van Zandvoort K;Silverman JD;CMMID COVID-19 Working Group;COVID-19 Genomics UK (COG-UK) Consortium;Diaz-Ordaz K;Keogh R;Eggo RM;Funk S;Jit M;Atkins KE;Edmunds WJ
通讯作者:
Edmunds WJ
影响因子:
2.4
作者:
Farkas K;Hillary LS;Thorpe J;Walker DI;Lowther JA;McDonald JE;Malham SK;Jones DL
通讯作者:
Jones DL
影响因子:
12.8
作者:
Hillary LS;Farkas K;Maher KH;Lucaci A;Thorpe J;Distaso MA;Gaze WH;Paterson S;Burke T;Connor TR;McDonald JE;Malham SK;Jones DL
通讯作者:
Jones DL
DOI:
10.1136/bmj.n1637
发表时间:
2021-07-06
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
García-Fiñana M;Hughes DM;Cheyne CP;Burnside G;Stockbridge M;Fowler TA;Fowler VL;Wilcox MH;Semple MG;Buchan I
通讯作者:
Buchan I
DOI:
10.1126/science.abh2644
发表时间:
2021-05-21
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Faria NR;Mellan TA;Whittaker C;Claro IM;Candido DDS;Mishra S;Crispim MAE;Sales FCS;Hawryluk I;McCrone JT;Hulswit RJG;Franco LAM;Ramundo MS;de Jesus JG;Andrade PS;Coletti TM;Ferreira GM;Silva CAM;Manuli ER;Pereira RHM;Peixoto PS;Kraemer MUG;Gaburo N Jr;Camilo CDC;Hoeltgebaum H;Souza WM;Rocha EC;de Souza LM;de Pinho MC;Araujo LJT;Malta FSV;de Lima AB;Silva JDP;Zauli DAG;Ferreira ACS;Schnekenberg RP;Laydon DJ;Walker PGT;Schlüter HM;Dos Santos ALP;Vidal MS;Del Caro VS;Filho RMF;Dos Santos HM;Aguiar RS;Proença-Modena JL;Nelson B;Hay JA;Monod M;Miscouridou X;Coupland H;Sonabend R;Vollmer M;Gandy A;Prete CA Jr;Nascimento VH;Suchard MA;Bowden TA;Pond SLK;Wu CH;Ratmann O;Ferguson NM;Dye C;Loman NJ;Lemey P;Rambaut A;Fraiji NA;Carvalho MDPSS;Pybus OG;Flaxman S;Bhatt S;Sabino EC
通讯作者:
Sabino EC